We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Type May Affect Heart Disease Risk

By LabMedica International staff writers
Posted on 28 Aug 2012
The blood type of an individual may affect their risk of coronary heart disease (CHD) as people with certain blood types are more likely to develop the disease than are others. More...


Studies have indicated that ABO blood group might influence plasma lipid level and recently, several genome-wide association studies found that variants at ABO locus were associated with plasma lipid levels and inflammatory markers that were associated with the CHD risk.
Scientists at the Harvard School of Public Health (Boston, MA, USA) examined data covering nearly 90,000 participants aged from 30 to 75 who were followed for 20 years or more in two large well-known American studies that included a cohort of 62,073 women and a cohort of 27,428 adults.

The proportions of men and women in the studies with various blood types were the same as in the general population, and the scientists were able to control for a number of factors that can affect health and heart disease risk, such as age, gender, race, body mass index, diet, smoking, menopause, and medical history.

The blood type AB is the rarest blood type, it occurs in around 7% of Americans, while type O, the most common, occurs in around 43%. Those with blood type AB had a 23% increased risk for heart disease, those with type B had an 11% increased risk, and those with type A had a 5% increased risk, compared to people with type O.

The mechanisms that cause blood type to affect heart disease risk were not investigated, but evidence from other studies gives some clues. Blood type A is linked to higher levels of low-density lipoprotein (LDL) cholesterol, the "bad" cholesterol that clogs up arteries. Blood type AB is linked to inflammation, which can affect how blood vessels work, and people with blood type O have higher levels of a compound that has a beneficial effect on blood flow and clotting.

Lu Qi, MD, PhD, the senior author of the study, said, "It is important to know your blood type, just as it is good to know your cholesterol and blood pressure levels. If you know you are at higher risk, you can reduce the risk by adopting a healthier lifestyle, such as eating right, exercising, and not smoking." Armed with findings like these, health care providers can tailor treatments more effectively. For instance, patients with blood type A could be advised to reduce cholesterol in their diet to lower their risk of heart disease. The study was published on August 14, 2012, in the journal Arteriosclerosis, Thrombosis and Vascular Biology.

Related Links:
Harvard School of Public Health



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Portable Electronic Pipette
Mini 96
New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study shows that periodic ctDNA screening after surgery can help guide a decision to begin adjuvant immunotherapy (Photo courtesy of Adobe Stock)

Blood Test Guides Post-Surgical Immunotherapy for Muscle-Invasive Bladder Cancer

After surgery for muscle-invasive bladder cancer, many patients face uncertainty about whether residual cancer cells remain in their bodies. Now, a new international phase 3 study has demonstrated that... Read more

Immunology

view channel
Image: When assessing the same lung biopsy sample, research shows that only 18% of pathologists will agree on a TCMR diagnosis (Photo courtesy of Thermo Fisher)

Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection

Lung transplant recipients face a significant risk of rejection and often require routine biopsies to monitor graft health, yet assessing the same biopsy sample can be highly inconsistent among pathologists.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.